South-East Asia (WHO region) vs Togo: New cases tested for RR-/MDR-TB
South-East Asia (WHO region)
91.0%
in 2024
Togo
100.0%
in 2024
South-East Asia (WHO region) rank
1st
Togo rank
1st
New cases tested for RR-/MDR-TB over time
- South-East Asia (WHO region)
- Togo
How they compare
Togo currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Togo's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 4 times across 17 shared years of data; in 2007 it was Togo ahead.
South-East Asia (WHO region) ranks 1st and Togo ranks 1st of 11 groups.
Across the 3 decades both report, South-East Asia (WHO region) averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | South-East Asia (WHO region) | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 0.3% | 0.2% | Togo |
| 2010s | 24.5% | 14.5% | 9.9% | South-East Asia (WHO region) |
| 2020s | 77.8% | 91.8% | 14.0% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South-East Asia (WHO region) or Togo?
- Togo, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between South-East Asia (WHO region) and Togo?
- 9.0%, with Togo ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Togo?
- 17 years are reported by both, from 2007 to 2024.
- How do South-East Asia (WHO region) and Togo rank globally for new cases tested for rr-/mdr-tb?
- South-East Asia (WHO region) ranks 1st and Togo ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.